Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 5, Pages 1388-1407Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm801126a
Keywords
-
Categories
Funding
- National Cancer Institute [POI CA-94000]
- W. M. Keck Foundation
- Lucille P. Markey Charitable Trust
- NIH [RR-15301, RR-01646]
Ask authors/readers for more resources
S-Adenosylmethionine decarboxylase (AdoMetDC) is a critical enzyme in the polyamine biosynthetic pathway and depends on a pyruvoyl group for the decarboxylation process. The crystal structures of the enzyme with various inhibitors at the active site have shown that the adenine base of the ligands adopts an unusual syn conformation when bound to the enzyme. To determine whether compounds that favor the syn conformation in solution would be more potent AdoMetDC inhibitors, several series of AdoMet substrate analogues with a variety of substituents at the 8-position of adenine were synthesized and analyzed for their ability to inhibit hAdoMetDC. The biochemical analysis indicated that an 8-methyl substituent resulted in more potent inhibitors, yet most other 8-substitutions provided no benefit over the parent compound. To understand these results, we used computational modeling and X-ray crystallography to study C-8-substituted adenine analogues bound in the active site.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available